Poor Outcomes for IgD Multiple Myeloma Patients Following High-Dose Melphalan and Autologous Stem Cell Transplantation: A Single Center Experience

Yong Pil Chong; Shin Kim; Ok Bae Ko; Ja Eun Koo; Danbi Lee; Sang Hyoung Park; Soo Jung Park; Daeho Lee; Sang We Kim; Cheolwon Suh

doi:10.3346/jkms.2008.23.5.819

Poor Outcomes for IgD Multiple Myeloma Patients Following High-Dose Melphalan and Autologous Stem Cell Transplantation: A Single Center Experience

Journal of Korean Medical Science ◽

10.3346/jkms.2008.23.5.819 ◽

2008 ◽

Vol 23 (5) ◽

pp. 819 ◽

Cited By ~ 6

Author(s):

Yong Pil Chong ◽

Shin Kim ◽

Ok Bae Ko ◽

Ja Eun Koo ◽

Danbi Lee ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

High Dose ◽

Single Center ◽

Single Center Experience ◽

Poor Outcomes ◽

High Dose Melphalan

Download Full-text

Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell transplantation: a single-center experience

Supportive Care in Cancer ◽

10.1007/s00520-021-06472-7 ◽

2021 ◽

Author(s):

Barbara Loteta ◽

Annalisa Paviglianiti ◽

Virginia Naso ◽

Anna Ferreri ◽

Tiziana Moscato ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Nausea And Vomiting ◽

High Dose ◽

Single Center ◽

Single Center Experience ◽

High Dose Melphalan

Download Full-text

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma

Leukemia Research ◽

10.1016/j.leukres.2006.09.021 ◽

2007 ◽

Vol 31 (8) ◽

pp. 1069-1075 ◽

Cited By ~ 18

Author(s):

Don M. Benson ◽

Patrick J. Elder ◽

Thomas S. Lin ◽

William Blum ◽

Sam Penza ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

High Dose ◽

High Dose Melphalan

Download Full-text

Gender-Specific Aspects in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: A Single-Center Experience

Oncology ◽

10.1159/000478265 ◽

2017 ◽

Vol 93 (5) ◽

pp. 295-301

Author(s):

Doris Posch ◽

Werner Rabitsch ◽

Philipp Wohlfarth ◽

Michael Leiner ◽

Edit Porpaczy ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Single Center ◽

Single Center Experience ◽

Gender Specific

Download Full-text

A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma

Bone Marrow Transplantation ◽

10.1038/s41409-019-0534-0 ◽

2019 ◽

Vol 54 (11) ◽

pp. 1881-1891

Author(s):

Noa Biran ◽

Scott D. Rowley ◽

David H. Vesole ◽

Shijia Zhang ◽

Michele L. Donato ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Phase I ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Conditioning Regimen ◽

High Dose ◽

High Dose Melphalan

Download Full-text

Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis

Leukemia & Lymphoma ◽

10.1080/10428194.2020.1783448 ◽

2020 ◽

Vol 61 (11) ◽

pp. 2714-2721

Author(s):

Ga-Young Song ◽

Sung-Hoon Jung ◽

Je-Jung Lee ◽

Jin Seok Kim ◽

Chang-Ki Min ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Propensity Score ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Conditioning Regimen ◽

High Dose ◽

High Dose Melphalan

Download Full-text

Tolerability of high dose chemotherapy and autologous stem cell transplantation in elderly patients with multiple myeloma: A single-center retrospective analysis

Current Research in Translational Medicine ◽

10.1016/j.retram.2020.04.001 ◽

2020 ◽

Vol 68 (3) ◽

pp. 139-144 ◽

Cited By ~ 2

Author(s):

H. Wiebach ◽

D. Gezer ◽

T.H. Brummendorf ◽

M. Crysandt ◽

S. Wilop

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Elderly Patients ◽

Retrospective Analysis ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

High Dose Chemotherapy ◽

High Dose ◽

Single Center

Download Full-text

High-dose melphalan with G-CSF-stimulated whole blood rescue followed by stem cell harvesting and busulphan/cyclophosphamide with autologous stem cell transplantation in multiple myeloma

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1703013 ◽

2001 ◽

Vol 27 (9) ◽

pp. 925-931 ◽

Cited By ~ 16

Author(s):

PC Huijgens ◽

HM Dekker-van Roessel ◽

AR Jonkhoff ◽

GC Admiraal ◽

S Zweegman ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Whole Blood ◽

High Dose ◽

Cell Harvesting ◽

High Dose Melphalan

Download Full-text

Early Versus Delayed Autologous Stem Cell Transplantation and Interferon Maintenance in Multiple Myeloma: Single-Center Experience of 18 Years

Transplantation Proceedings ◽

10.1016/j.transproceed.2015.12.031 ◽

2016 ◽

Vol 48 (1) ◽

pp. 177-184 ◽

Cited By ~ 10

Author(s):

P. Remenyi ◽

G. Varga ◽

G. Mikala ◽

M. Reti ◽

L. Gopcsa ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Single Center ◽

Single Center Experience

Download Full-text

High-dose melphalan on day 2 versus 1 before autologous stem cell transplantation for multiple myeloma.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.6545 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 6545-6545

Author(s):

K. Rakszawski ◽

J. J. Drabick ◽

N. G. Dolloff ◽

J. M. Sivik ◽

J. Malysz ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

High Dose ◽

High Dose Melphalan

Download Full-text

Targeted radiotherapy delivered by an yttrium-90 radio-labelled Anti-CD66 monoclonal antibody with high dose melphalan compared to melphalan alone, prior to autologous stem cell transplantation for multiple myeloma

http://isrctn.org/> ◽

10.1186/isrctn11933044 ◽

2012 ◽

Author(s):

Kim Orchard

Keyword(s):

Multiple Myeloma ◽

Monoclonal Antibody ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

High Dose ◽

Targeted Radiotherapy ◽

High Dose Melphalan ◽

Yttrium 90

Download Full-text